Koers Herborium Group, Inc. Other OTC
Aandelen
HBRM
US42703A2087
Biotechnologie & Medisch Onderzoek
Omzet 2010 | 262K 242K | Omzet 2011 | 234K 216K | Marktkapitalisatie | 210K 194K |
---|---|---|---|---|---|
Nettowinst (verlies) 2010 | - 0 | Nettowinst (verlies) 2011 | - 0 | EV/omzet 2010 | 10,7 x |
Nettoschuld 2010 | 588K 542K | Nettoschuld 2011 | 621K 573K | EV/omzet 2011 | 3,55 x |
K/w-verhouding 2010 |
-4,35
x | K/w-verhouding 2011 |
-0,97
x | Werknemers | - |
Dividendrendement 2010 * |
-
| Dividendrendement 2011 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04-06-02 |
John Donahue
AUD | Comptroller/Controller/Auditor | 74 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Agnes Olszewski
CEO | Chief Executive Officer | 67 | 04-06-02 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,61% | 122 mld. | |
+17,75% | 112 mld. | |
+17,23% | 25,91 mld. | |
-24,11% | 19,33 mld. | |
-18,56% | 16,17 mld. | |
-18,47% | 15,6 mld. | |
-47,75% | 14,65 mld. | |
+57,35% | 14,34 mld. | |
+5,62% | 14 mld. |